Dr Anand Burman has been appointed as the new chairman of homegrown FMCG major Dabur India. He is the son of Dabur India’s chairman emeritus, AC Burman.
Burman, who had been serving as vice-chairman of the company, replaces VC Burman, who stepped down as director and chairman of the Rs 2,234-crore company. Amit Burman, who was earlier heading the wholly-owned subsidiary Dabur Foods, is the new vice-chairman of the company. Mohit Burman, who spearheaded Dabur India’s Rs 143-crore acquisition of Balsara Hygiene and Home Care over a year ago, has been inducted as full-time director on the board.
Outgoing chairman VC Burman said in a statement: “The reconstitution of the board will provide renewed vigour to Dabur India’s ambitious growth charter, and give the younger generation an opportunity to contribute towards strengthening its position as a global leader in the health and wellness spectrum.”
The 55-year-old Anand Burman said: “Dabur India is clearly on a high growth path and continues to grow at a fast pace. I am confident that this team will continue to deliver sustainable results in the long term.”
Dr Burman has particular interests in the areas of research and development in the Pharmaceutical Sciences as well as Biotechnology and Technology issues. He has a B.Sc. in Chemistry from the University of Wisconsin and a M.Sc. in Chemistry from the University of Kansas. His doctorate was in the area of Pharmaceutical Chemistry from the University of Kansas in 1980.
Amit is the son of late GC Burman, who died in 2001. Mohit is the son of outgoing chairman VC Burman. AC Burman and VC Burman are brothers, while GC Burman was their cousin.
Dabur India posted a 17.93 per cent increase in net profit at Rs 54.06 crore for the first quarter ended June 30, as compared to Rs 45.84 crore for the same period last year. Total income of the company increased 14.75 per cent to Rs 451.04 crore for the quarter, from Rs 393.05 crore for the corresponding period a year ago, Dabur India informed the Bombay Stock Exchange (BSE).